{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/28/3302753/0/en/Cogent-Biosciences-Announces-FDA-Acceptance-of-New-Drug-Application-NDA-with-Priority-Review-for-Bezuclastinib-in-Combination-with-Sunitinib-for-Patients-with-GIST.html", "message": "News view counter 763434 successfully enlarged"}